RUA — Rua Bioscience Income Statement
0.000.00%
Last trade - 00:00- NZ$8.05m
- NZ$8.61m
- NZ$1.51m
- 11
- 41
- 50
- 24
Annual income statement for Rua Bioscience, fiscal year end - June 30th, NZD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.024 | 0.358 | 0.086 | 1.51 |
| Cost of Revenue | |||||
| Gross Profit | — | -0.104 | 0.018 | -0.118 | 0.535 |
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.19 | 7.61 | 6.5 | 13.9 | 4.81 |
| Operating Profit | -6.19 | -7.58 | -6.14 | -13.8 | -3.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -6.17 | -7.49 | -5.96 | -13.7 | -3.46 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.42 | -8.64 | -5.96 | -13.7 | -3.46 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.42 | -8.64 | -5.96 | -13.7 | -3.46 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.42 | -8.64 | -5.96 | -13.7 | -3.46 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.03 | -0.051 | -0.033 | -0.024 | -0.018 |